轻度COVID-19感染不改变ART治疗女性的卵巢储备
该前瞻性观察研究于2020年6月至12月在巴黎Tenon医院ART单元纳入118名因生育问题接受IVF/ICSI、生育力保存、冻胚移植或人工授精的女性,所有受试者进行COVID快速检测并比较抗体阳性与阴性组间AMH浓度变化。结果显示两组AMH变化无显著差异,提示轻度COVID-19感染似乎不改变以AMH评估的卵巢储备,但需进一步研究评估对妊娠结局的影响。
要点
- 轻度COVID-19感染后AMH变化与未感染者无显著差异
- 研究纳入118名ART女性,其中11.9%为COVID快速检测阳性
- 需进一步研究评估COVID-19对ART妊娠结局的影响
核心结论
- 轻度COVID-19感染似乎不改变以AMH浓度评估的卵巢储备。
- 尽管结果令人安心,仍需进一步研究评估COVID-19对ART女性妊娠结局的影响。
研究设计与样本
- 前瞻性观察研究,于2020年6月至12月在巴黎Tenon医院ART单元进行。
- 纳入因生育问题接受IVF/ICSI、生育力保存、冻胚移植或人工授精,且在ART治疗前12个月内完成AMH检测的女性。
- 所有女性接受COVID快速检测,比较阳性与阴性组间AMH浓度。
- 研究人群共118名女性,其中11.9%(14/118)为COVID快速检测阳性。
- 所有受试女性均无重型COVID-19感染史。
主要发现
- COVID快速检测阳性组与阴性组间,初始AMH浓度与ART治疗期间AMH浓度的差值无显著差异(-1.33 ng/ml [-0.35 to -1.61] vs -0.59 ng/ml [-0.15 to -1.11],P = 0.22)。
临床怎么用
- 对于有轻度COVID-19感染史的ART女性,可参考AMH评估卵巢储备,但需结合个体情况。
- 临床咨询时可告知患者轻度COVID-19感染可能不影响卵巢储备,但妊娠结局影响尚不明确。
局限性
- 研究未评估COVID-19对ART妊娠结局的影响。
- 样本量有限,需进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does mild COVID-19 infection affect the ovarian reserve of women undergoing an assisted reproductive technology (ART) protocol? DESIGN: A prospective observational study was conducted between June and December 2020 at the ART unit of Tenon Hospital, Paris. Women managed at the unit for fertility issues by in-vitro fecundation, intracytoplasmic sperm injection (IVF/ICSI), fertility preservation, frozen embryo transfer or artificial insemination, and with an anti-Müllerian hormone (AMH) test carried out within 12 months preceding ART treatment, were included. All the women underwent a COVID rapid detection test (RDT) and AMH concentrations between those who tested positive (RDT positive) and those who tested negative (RDT negative). RESULTS: The study population consisted of 118 women, 11.9% (14/118) of whom were COVID RDT positive. None of the tested women presented with a history of severe COVID-19 infection. The difference between the initial AMH concentration and AMH concentration tested during ART treatment was not significantly different between the COVID RDT positive group and COVID RDT negative group (-1.33 ng/ml [-0.35 to -1.61) versus -0.59 ng/ml [-0.15 to -1.11], P = 0.22). CONCLUSION: A history of mild COVID-19 infection does not seem to alter the ovarian reserve as evaluated by AMH concentrations. Although these results are reassuring, further studies are necessary to assess the effect of COVID-19 on pregnancy outcomes in women undergoing ART.
引用
- Kolanska K, Hours A, Jonquière L, et al. Mild COVID-19 infection does not alter the ovarian reserve in women treated with ART. Reprod Biomed Online. 2021. PMID: 34711516. doi:10.1016/j.rbmo.2021.09.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。